Takae Seido, Lee Jung Ryeol, Mahajan Nalini, Wiweko Budi, Sukcharoen Nares, Novero Virgilio, Anazodo Antoinette Catherine, Gook Debra, Tzeng Chii-Ruey, Doo Alexander Kenenth, Li Wen, Le Chau Thi Minh, Di Wen, Chian Ri-Cheng, Kim Seok Hyun, Suzuki Nao
Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, Kawasaki, Japan.
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul, South Korea
Front Endocrinol (Lausanne). 2019 Oct 15;10:655. doi: 10.3389/fendo.2019.00655. eCollection 2019.
At present, fertility is one of the main concerns of young cancer patients. Following this trend, "fertility preservation (FP)" has been established and has become a new field of reproductive medicine. However, FP for child and adolescent (C-A) cancer patients is still developing, even in advanced countries. The aim of the present study was to assess the barriers to FP for C-A patients by investigating the current status of FP for C-A patients in Asian countries, which just have started FP activities. A questionnaire survey of founding members of the Asian Society for Fertility Preservation (ASFP) was conducted in November 2018. Of the 14 countries, 11 country representatives replied to this survey. FP for C-A patients is still developing in Asian countries, even in Australia, Japan, and Korea, which have organizations or academic societies specialized for FP. In all countries that replied to the present survey, the patients can receive embryo cryopreservation (EC), oocyte cryopreservation (OC), and sperm cryopreservation (SC) as FP. Compared with ovarian tissue cryopreservation (OTC), testicular tissue cryopreservation (TTC) is an uncommon FP treatment because of its still extremely experimental status (7 of 11 countries provide it). Most Asian countries can provide FP for C-A patients in terms of medical technology, but most have factors inhibiting to promote FP for C-A patients, due to lack of sufficient experience and an established system promoting FP for C-A patients. "Don't know how to provide FP treatment for C-A" is a major barrier. Also, low recognition in society and among medical staff is still a particularly major issue. There is also a problem with cooperative frameworks with pediatric departments. To achieve high-quality FP for C-A patients, a multidisciplinary approach is vital, but, according to the present study, few paramedical staff can participate in FP for C-A patients in Asia. Only Australia and Korea provide FP information by video and specific resources. The present study demonstrated the developing status of FP for C-A patients in Asian countries. More intensive consideration and discussion are needed to provide FP in Asian societies based on the local cultural and religious needs of patients.
目前,生育问题是年轻癌症患者主要关注的问题之一。顺应这一趋势,“生育力保存(FP)”应运而生,并已成为生殖医学的一个新领域。然而,即使在发达国家,儿童和青少年(C-A)癌症患者的生育力保存仍在发展之中。本研究的目的是通过调查亚洲国家C-A患者生育力保存的现状,评估C-A患者生育力保存面临的障碍,这些亚洲国家刚刚开始开展生育力保存活动。2018年11月对亚洲生育力保存协会(ASFP)的创始成员进行了问卷调查。在14个国家中,11个国家的代表回复了此次调查。即使在澳大利亚、日本和韩国这些设有专门的生育力保存组织或学术团体的国家,亚洲国家C-A患者的生育力保存仍在发展之中。在所有回复本次调查的国家中,患者都可以接受胚胎冷冻保存(EC)、卵母细胞冷冻保存(OC)和精子冷冻保存(SC)作为生育力保存方法。与卵巢组织冷冻保存(OTC)相比,睾丸组织冷冻保存(TTC)是一种不太常见的生育力保存治疗方法,因为其仍处于极其实验性的阶段(11个国家中有7个提供这种方法)。就医疗技术而言,大多数亚洲国家能够为C-A患者提供生育力保存,但由于缺乏足够的经验以及促进C-A患者生育力保存的既定体系,大多数国家都存在阻碍C-A患者生育力保存推广的因素。“不知道如何为C-A患者提供生育力保存治疗”是一个主要障碍。此外,社会和医务人员的认知度低仍然是一个特别重大的问题。儿科部门的合作框架也存在问题。为了实现为C-A患者提供高质量的生育力保存,多学科方法至关重要,但根据本研究,在亚洲,很少有辅助医疗人员能够参与C-A患者的生育力保存工作。只有澳大利亚和韩国通过视频和特定资源提供生育力保存信息。本研究展示了亚洲国家C-A患者生育力保存的发展状况。需要根据患者当地的文化和宗教需求,在亚洲社会提供生育力保存方面进行更深入的思考和讨论。